Barclays Maintains Underweight on Clorox, Lowers Price Target to $102

Benzinga Newsdesk www.benzinga.com Negative 89.5%

Neg 89.5% Neu 0% Pos 0%

Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $109 to $102.